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Kin1 and Kin2 are Saccharomyces cerevisiae counterparts of Par-1, the Caenorhabditis elegans kinase essential for the
establishment of polarity in the one cell embryo. Here, we present evidence for a novel link between Kin1, Kin2, and the
secretory machinery of the budding yeast. We isolated KIN1 and KIN2 as suppressors of a mutant form of Rho3, a
Rho-GTPase acting in polarized trafficking. Genetic analysis suggests that KIN1 and KIN2 act downstream of the
Rab-GTPase Sec4, its exchange factor Sec2, and several components of the vesicle tethering complex, the Exocyst. We show
that Kin1 and Kin2 physically interact with the t-SNARE Sec9 and the Lgl homologue Sro7, proteins acting at the final
stage of exocytosis. Structural analysis of Kin2 reveals that its catalytic activity is essential for its function in the secretory
pathway and implicates the conserved 42-amino acid tail at the carboxy terminal of the kinase in autoinhibition. Finally,
we find that Kin1 and Kin2 induce phosphorylation of t-SNARE Sec9 in vivo and stimulate its release from the plasma
membrane. In summary, we report the finding that yeast Par-1 counterparts are associated with and regulate the function
of the exocytic apparatus via phosphorylation of Sec9.
INTRODUCTION
Par-1 has been implicated in providing intracellular polar-
ization cues in various biological systems. Initially, Par-1 has
been described in Caenorhabditis elegans as one of the “par-
titioning” genes essential for anterior-posterior axis specifi-
cation and asymmetry of zygote division (Kemphues et al.,
1988). Homologous genes have been characterized in Schizo-
saccharomyces pombe (kin1) (Levin and Bishop, 1990), Dro-
sophila melanogaster (dPAR-1) (Tomancak et al., 2000), and
mammalian cells (mPARs: p78, EMK, MARK) (Drewes et al.,
1995; Bohm et al., 1997). The mechanism of cell polarity
regulation by Par-1 seems to differ depending on the organ-
ism and the cellular context. Some reports link Par-1 func-
tion to restricting localization of polarity determinants: P
granules and PIE-1 in C. elegans (Kemphues et al., 1988;
Tenenhaus et al., 1998); Oscar, Orb, BicD, and Egl in Dro-
sophila oocyte (Tomancak et al., 2000; Huynh et al., 2001;
Vaccari and Ephrussi, 2002); and Par-3 via 14-3-3 in Drosoph-
ila follicular epithelium (Benton and Johnston, 2003). Others
find that Par-1 regulates stability, density, and/or organiza-
tion of the microtubule cytoskeleton as in Drosophila and
mammalian cells (Drewes et al., 1997; Shulman et al., 2000;
Cox et al., 2001; Huynh et al., 2001; Doerflinger et al., 2003;
Cohen et al., 2004).
In the budding yeast Saccharomyces cerevisiae, the Par-1
counterparts Kin1 and Kin2 have been isolated by homology
to the kinase family of viral oncogenes (Levin et al., 1987).
They belong to the Snf1 kinase family of the Ca2/calmod-
ulin-dependent kinase II (CaMK) group (Hanks et al., 1988).
Kin1 and Kin2 are structurally similar serine/threonine ki-
nases with an N-terminally located catalytic domain and
C-terminal regulatory domain (Lamb et al., 1991; Donovan et
al., 1994). The catalytic core and the C-terminal 42-amino
acid tail are highly conserved between S. pombe, S. cerevisiae,
C. elegans, D. melanogaster, and mammalian orthologues of
Par-1. Therefore, S. cerevisiae, as a polarized organism highly
amenable to genetic analysis, represents an advantageous
model to study yeast Par-1 orthologues. However, little is
known about the function of Kin1 and Kin2 in S. cerevisiae.
This work investigates the role of Kin1 and Kin2 proteins
in polarized exocytosis in yeast. In S. cerevisiae, polarity is
manifested by asymmetric growth of the bud, which re-
quires polarized transport of Golgi-derived vesicles and
their subsequent docking and fusion with the plasma mem-
brane at the bud tip. Golgi-to-plasma membrane transport is
dependent on the actin cytoskeleton and Rho/Rab GTPases,
such as Rho3, Cdc42, and Sec4. Definition of the docking site
and vesicle tethering is mediated by a multiprotein Exocyst
complex, comprised of eight subunits: Sec3, Sec5, Sec6, Sec8,
Sec10, Sec15, Exo70, and Exo84 (Guo et al., 1999). After
docking, vesicle fusion with the plasma membrane involves
correct pairing of one vesicle SNARE, Snc1/2, with two
membrane t-SNAREs: Sso1/2 and Sec9 (Aalto et al., 1993;
Protopopov et al., 1993; Brennwald et al., 1994). Although the
aforementioned molecules constitute the core of the secre-
tory machinery, polarized exocytosis is fine-tuned by many
additional components.
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Here, we report that yeast Par-1 orthologues regulate
exocytosis. We show that Kin1 and Kin2 genetically interact
with multiple components of the late exocytic machinery
and physically associate with the t-SNARE Sec9 and the
SNARE-binding protein Sro7. We demonstrate that Kin1
and Kin2 induce phosphorylation of Sec9 and its release
from the plasma membrane, which, presumably, promotes
incorporation of Sec9 into novel SNARE complexes. We
further find that the conserved 42-amino acid tail of the
yeast Par-1 ortholog plays a role in the autoinhibition of the
kinase function in the secretory pathway of S. cerevisiae.
MATERIALS AND METHODS
Media and Reagents
Yeast cells were grown in either YP medium (1% bacto-yeast extract, 2% bacto-
peptone; Difco, Detroit, MI), S medium (0.67% yeast nitrogen base; Difco), or SC
medium (0.67% yeast nitrogen base with dropout selection-appropriate amino
acid nutrients) supplemented with 2% glucose or 1% galactose. Sorbitol, sodium
azide, sodium fluoride, N-ethylmaleimide, -mercaptoethanol, Triton X-100, and
protease inhibitors were obtained from Sigma-Aldrich (St. Louis, MO). Zymolase
(100T) was purchased from Seikagaku (Tokyo, Japan). 125I-Protein A and
[32P]ATP, 35S-TransLabel, [35S]methionine, and [32P]orthophosphate were ob-
tained from PerkinElmer Life and Analytical Sciences (Boston, MA) and protein
A-Sepharose CL-4B from Amersham Biosciences (Piscataway, NJ). Molecular
weight markers and Tween 20 were from Bio-Rad (Hercules, CA). Restriction
enzymes, calf intestinal phosphatase, and -phosphatase were purchased from
New England Biolabs (Beverly, MA).
Yeast Genetic Techniques
Transformations were performed using the lithium acetate method (Becker
and Guarente, 1991). Crosses of strains, tetrad dissection, and diploid sporu-
lation were performed as described previously (Guthrie, 1991).
Antibodies
Rabbit antisera were raised against glutathione S-transferase (GST)-fusion
proteins containing residues 852-1032 of the C terminus of Kin1 and contain-
ing residues 964-1121 of the C terminus of Kin2 (Cocalico Biologicals, Reams-
town, PA). Antibodies were affinity purified as described previously (Lehman
et al., 1999).
Plasmid Construction and Generation of Mutants
Constructs were generated by polymerase chain reaction (PCR) amplification
by using primers (QIAGEN Operon, Alameda, CA) incorporating appropriate
restriction sites. Primers were designed to incorporate 1000 base pairs
upstream of the open reading frame (ORF) and 250 base pairs downstream of
the stop codon into the construct. SalI/EcoR1 sites were used to subclone
full-length KIN1 into the pRS426 vector. To generate KIN2 constructs, KIN2
(1–1147), kin2-CT (521–1147), KIN2-NT (1–526), kin2-KD (K128M), KIN2-42
(1–1106), and 800 base pairs of the sequence upstream of the ORF were
introduced into pRS426 as a NotI/EcoR1 segment, and subsequently, wild-
type and mutant KIN2 ORF sequences were subcloned into the same vector by
using EcoR1/XhoI sites. Fusion PCR technique was used to generate KIN2-NT,
KIN2-42, and kin2-KD. For the fusion reaction, segments with overlapping
sequences generated in the first round of the amplification were resolved on
1.5% low-temperature agarose gel, cut out, and used as templates in the
second round of the PCR amplification. Catalytic domains of SNF1, HSL1,
GIN4, KCC4, YPL141C, KIN4, and YPL150W were mapped by BLAST se-
quence alignment with KIN2. NotI/XhoI sites were used to subclone HSL1
(1–462), GIN4 (1–432), KCC4 (1–437), YPL141C (1–387), and YPL150W (1–426)
into pRS426 vector. NotI/SalI sites were used to subclone SNF1 (1–432) and
KIN4 (1–366) into the pRS426 vector. Galactose-inducible KIN1 and KIN2
constructs were generated by insertion of PCR-amplified fragments behind
the GAL promoter of GAL/HIS/CEN (BamH1/SalI sites used) and GAL/LEU/
CEN (BamH1/XhoI sites used) vectors, respectively. Generation of high copy
SEC9 construct and Sec9-CT (402–651) GST-fusion protein were described
elsewhere (Rice et al., 1997). Sec9-NT1 (1–168) and Sec9-NT2 (166–401) GST-
fusion proteins were obtained by subcloning Sec9-NT1 and Sec9-NT2 into the
BamH1/SalI and BamH1/EcoR1 sites, respectively, of the pGEX4T1 vector
(Amersham Biosciences). The Sec9-NT2-S315A mutant was created by fusion
PCR via mutation-incorporating primers. All mutants were verified by se-
quencing. Generation of GST-KIN2 kinase domain (1–520) construct was
obtained by subcloning a PCR-generated fragment containing kin2-NT (1–520)
into the BamHI-XhoI sites of the pGEX4T1 vector. The C-terminal Kin2 frag-
ments kin2-CT (523–1147) and kin2-CT42 (523–1106) were placed under the
control of a T7 promoter for transcription and translation by PCR amplifica-
tion. The upstream oligo was designed for translation beginning at residue
532 in the KIN2 coding sequence. The downstream oligo was designed to
anneal 40 base pairs distal to the stop codon of KIN2. PCR products for
coupled translation/transcription were generated using templates containing
either KIN2 or KIN2-42 mutant. Translation of each PCR product resulted in
a radiolabeled protein of the expected size on SDS-PAGE.
Suppression Assays
Late sec mutant cells were transformed with high copy plasmids (e.g., vector,
KIN1, and KIN2) or a galactose-inducible Kin2 construct (vector and
GALKIN2)and grown on selective medium, picked into microtiter plates, and
replica plated onto YP-D medium (YP supplemented with 2% glucose) or
YP-Gal (YP supplemented with 1% galactose). Transformants were tested for
growth at permissive (25°C) and restrictive (14, 33, 35, and 37°C) tempera-
tures.
Two-Hybrid Analysis
ORFs of kin2-CT (521–1147) and kin2-CT42 (521–1106) were subcloned as
N-terminal fusion fragments into NcoI/BamH1 sites of pAS1-CYH2 GAL4-
binding domain vector (BD). ORFs of KIN2 (1–1147), KIN2-NT (1–526),
kin2-CT (521–1147), KIN2-FL42 (1–1106), and kin2-CT42 (521–1147) were
inserted as N-terminal fusion fragments into NcoI/BamH1 sites of pACT2
GAL4-activation domain vector (AD). Constructs were transformed into the
PJ694 strain containing GAL4-inducible HIS3 and ADE reporter genes. Con-
struct expression was verified by Western blotting. Transformants expressing
interacting proteins gained the ability to grow on –His and –Ade media. As a
control empty BD and AD vectors were analyzed for the interaction with each
AD and BD fusion construct, respectively. Only signals detected in the ab-
sence of control background were considered positive.
In Vitro Binding Assays
PCR generated fragments containing kin2-CT (523–1147) and kin2-CT42
(523–1106) were placed under control of a T7 promoter and in vitro tran-
scribed and translated using a coupled reticulocyte lysate transcription/
translation system (TnT; Promega, Madison, WI) in the presence of [35S]me-
thionine. The radiolabeled proteins were diluted in binding buffer (10 mM
HEPES-KOH, pH 7.4., 140 mM KCl, 2 mM MgCl2, 0.5% Triton) with GST-Kin2
kinase domain (present at 1 M) for 1 h at 4°C. Supernatant and pellet
fractions were separated and run on a 7% gel, dried, and exposed to film.
Binding of radiolabeled proteins was quantified using the PhosphorImager
screen and STORM ImageQuant software (Amersham Biosciences).
Construction of Deletion Strains
Gene disruption was performed via homologous recombination. Initially,
flanking sequences upstream and downstream of the target ORF were intro-
duced into the integration vector, respectively, upstream and downstream of
the coding sequence of the appropriate selection marker. Plasmids were
linearized before the transformation. The KIN1 gene was disrupted by the
insertion of the LEU2 marker via pRS305 LEU2 vector. KIN2 gene was dis-
rupted by the insertion of the HIS3 marker via pRS303 HIS3 vector. The
genotype of the yeast strain transformed with these constructs was MAT a/;
ura3-52/ura3-52; leu2-3112/leu2-3112; his3-200/his3-200. Diploids were se-
lected on either –His or –Leu medium and sporulated. Tetrads were dissected
and analyzed for the presence of the selective markers and the viability at
different temperatures. Disruption was confirmed by PCR and immunoblot-
ting with -Kin1 and -Kin2 antibodies. Crossing of the single kin1 and
kin2 deletion strains generated a strain with the double deletion kin1,
kin2, which was analyzed in a similar manner. The SNF1 gene was disrupted
using a purified PCR product containing SNF1 sequences flanking the Kana-
mycin gene (snf1::KanR), which was transformed into the wild-type strain
and in the strain homozygous for the KIN1 deletion and heterozygous for the
KIN2 deletion: MAT a/a; kin1::LEU2/kin1::LEU2; KIN2/kin2::HIS3; leu2-
3112/leu2-3112; his3-200/his3-200; ura3-52/ura3-52 to create the triple dele-
tion mutant kin1, kin2, snf1. YPD-G418 plates were used for the selection
of the KanR-containing transformants. Diploids were sporulated, and tetrads
were analyzed for marker distribution. Generation of the triple mutant kin1,
kin2, snf1 was confirmed by PCR.
Subcellular Fractionation
Procedure was described in detail previously (Lehman et al., 1999). Three
strains were used: vector only (pRS426), KIN1 on high copy vector, and KIN2
on high copy vector. Cells were washed, spheroplasted, lysed, and divided
into two pools, which were subjected to the differential treatment with or
without Triton X-100 and centrifuged at 30,000  g. Supernatant and pellet
fractions were isolated and normalized for further analysis. Samples boiled in
SDS sample buffer were subjected to 7% SDS-PAGE and blotted with affinity-
purified antibodies to Kin1, Kin2, and Sso1/2. Signal was quantified using the
PhosphorImager screen and STORM ImageQuant software (Amersham Bio-
sciences).
Yeast Par-1 Orthologs Function in Exocytosis
Vol. 16, February 2005 533
BglII Secretion Assays
Secretion assays examining the effect of multicopy KIN2 were performed on
sec15-1 mutant cells (ura3-52; sec15-1) transformed with KIN2 on a high copy
vector or vector only (pRS426). Cells were grown overnight at 25°C and then
shifted to 36°C for 1 h. Cells were then processed for BglII secretion as
described previously (Adamo et al., 1999). Secretion assays on GAL induced
KIN1 were performed on sec1-1 mutant cells (GAL, ura3-52; leu2-3112; his3-
200; sec1-1) containing vector only (GAL/LEU2) or galactose inducible KIN1
on GAL/LEU2integrative vector as well as a wild-type control strain. Cells
were grown overnight to an OD599  0.5 in YP-raffinose (3%) medium at 25°C
and then induced with 1% galactose for 2 h before shifting the cells to 33°C for
2 h. Cells were then processed for BglII secretion as described previously
(Adamo et al., 1999).
Native Immunoprecipitation
Cells from strains containing either high copy KIN1, KIN2, or vector alone
were grown O/N in SC-D medium to OD599  0.5 and then shifted for 2 h to
grow in YP-D medium at 25°C to OD599  1 to the total of 266 OD units.
Subsequently, cells were harvested, washed in ice-cold 10:20:20 buffer (10 mM
Tris, 20 mM sodium azide, 20 mM sodium fluoride), and spheroplasted in
17.8 ml of spheroplast buffer (100 mM Tris, 20 mM sodium azide, 20 mM
sodium fluoride, 1.2 M sorbitol, 21 mM -mercaptoethanol, 0.1 mg/ml 100T
Zymolyase) for 30 min at 37°C. Spheroplasts were lysed in 8.8 ml of ice-cold
lysis buffer (20 mM HEPES-KOH, 150 mM KCl, 0.5% IGEPAL) with protease
inhibitors (PIC): 2 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 1 mM phe-
nylmethylsulfonyl fluoride, 20 M Pepstatin A, 2 g/ml leupeptin, aprotinin,
and antipain. The insoluble material was pelleted by 10-min spin in a 4°C
Microfuge, and the supernatant was used to set up immunoprecipitation (IP)
reactions (1 ml/1 IP). Saturating amounts of affinity purified antibodies to
Kin1 and Kin2 were incubated with the lysate for 1.5 h on ice. In parallel,
control IPs were set up with equal amounts of purified preimmune IgG. Next,
protein A-Sepharose was added to the lysates (60 l of 1:1 suspension per IP),
and tubes were placed on a nutator for 1 h. Beads were washed four times
with lysis buffer and boiled in 100 l of sample buffer. Samples were subjected
to SDS-PAGE, transferred to the nitrocellulose membrane, and immuno-
blotted with polyclonal antibodies to Kin1, Kin2, Sec9, and Sro7 followed by
I125-protein A secondary.
Dithiosuccinnimidylpropionate (DSP) Cross-linking
Strains containing high copy SEC9 and high copy KIN1 were grown overnight
in SD (S medium with 2% glucose). Six OD units of cells were labeled with
[35S]methionine and cysteine in 4 ml for 1 h at 30°C. Cross-linking and
immunoprecipitation were performed as described previously (Lehman et al.,
1999). Labeled cells were washed in phosphate-buffered saline (PBS)-azide,
spheroplasted in 1 ml of spheroplast buffer, and lysed in 300 l of PBS with
PIC. The lysate was divided into two pools, one treated with the chemical
cross-linker DSP dissolved in dimethyl sulfoxide (DMSO), and the control
pool was treated with DMSO only. The cross-linker was quenched by ammo-
nium acetate, samples were boiled in 5 boiling buffer (5% SDS, 50 mM Tris,
pH 8.0, 25 mM EDTA) and diluted 20 with IP buffer (10 mM Tris, pH 8, 150
mM NaCl, 0.5% Tween 20, 0.1 mM EDTA). Cell lysates were then subjected to
two rounds of IPs. First, samples from both pools were incubated with
affinity-purified antibodies to -Kin1, -Sec9, and preimmune IgG overnight
at 4°C. Immune complexes were pooled via protein A-Sepharose. For the
second round of IPs beads were resuspended in the reducing boiling buffer
(1% SDS, 10 mM Tris, pH 8.0, 5 mM EDTA, 0.1 mM dithiothreitol [DTT]),
boiled, diluted with IP buffer, and supernatants were subjected to IPs with
either affinity-purified -Kin1 or affinity-purified -Sec9 antibodies. Samples
were boiled and resolved on 7% SDS-PAGE, and a 35S signal was detected by
autoradiography.
Nonnative Immunoprecipitation and Phosphatase
Treatment
Yeast strains containing high copy SEC9 and either inducible KIN2 on GAL/
LEU/CEN integrative vector or GAL/LEU/CEN empty vector were grown in
SC medium with 3% raffinose overnight and induced with 1% galactose for
4 h at 25°C. Then, 100 OD units/each were harvested, washed, spheroplasted
in Eppendorf tubes (5 OD/tube), and lysed in 40 l/tube TEAE/sorbitol (10
mM triethanolamine, 1 mM EDTA, pH 7.2, 0.8 M sorbitol with 1 protease
inhibitor mix). Lysates were centrifuged, combined with an equal volume of
2 boiling buffer (10 mM Tris, pH 8.0, 25 mM EDTA pH 8.0, 1% SDS), boiled
at 95°C for 5 min, and diluted 20 with IP buffer (10 mM Tris, pH 8.0, 150 mM
NaCl, 0.1 mM EDTA, 0.5% Tween 20). Combined supernatants were distrib-
uted into Eppendorf tubes (1.4 ml/tube) and immunoprecipitated with anti-
sera to Sec9 (6 l/tube) overnight on ice. Immune complexes were pooled
down with protein A-Sepharose (65 l/tube) for 2 h at 4°C and washed with
IP buffer five times. Combined beads were distributed into Eppendorf tubes
(25-l bed volume/tube), which were subjected to five treatments: 1) boiled
immediately; 2) incubated 1:1 with 2 restriction buffer 3 and 2 l/tube of
calf intestinal phosphatase (CIP) for 30 min at 37°C; 3) incubated with 2
buffer 3 only for 30 min at 37°C (mock control for CIP); 4) incubated 1:1 with
2 -phosphatase buffer and -phosphatase (1.5 l/tube) for 30 min at 30°C;
and 5) incubated with 2 -phosphatase buffer only for 30 min at 30°C (mock
control for -phosphatase). Samples were boiled, separated on an 8% gel, and
immunoblotted with -Sec9 antibody.
Purification of the Recombinant Proteins
All GST-fusion proteins were produced, purified, and their protein concen-
trations estimated as described previously (Rossi et al., 1997).
In Vitro Kinase Assays
Yeast strains containing high copy KIN1, KIN2, or empty vector were grown
on SC-D (SC medium with 2% glucose) overnight and switched to YP-D
medium for 2.5 h. Cells were harvested (33 OD units/1 IP reaction), washed
in 10:20:20 buffer, spheroplasted, lysed, and subjected to native immunopre-
cipitation with antibodies to Kin1, Kin2, or preimmune serum as described
above. Immune complexes were pulled down with protein A-Sepharose (60
l of 1:1 slurry/1 IP), beads were washed twice with lysis buffer and twice
with PK buffer (50 mM Tris, pH 7.5, 5 mM MgCl2), and combined and
distributed into Eppendorf tubes. For one kinase reaction (total volume of 50
l), we used 25 l of 1:1 bead slurry, 1.5 M recombinant protein, 1 PKi
buffer (50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM DTT), 0.1 mM cold ATP, and
1 l of [32P]ATP. The kinase reaction was incubated at 30°C for 30 min, spun,
and the supernatant containing recombinant proteins was boiled in an equal
volume of sample buffer. Samples were subjected to 15% SDS-PAGE, and gels
were dried and exposed to film.
In Vivo Kinase Assays
Cells containing multicopy SEC9 and GAL-KIN2 (GAL-KIN2/CEN/LEU2) or
empty vector control (GAL/CEN/LEU2) were grown O/N in S medium with
3% raffinose to an OD599 of 0.5. Next day the cells were split in half and
shifted into fresh medium containing either S with 2% raffinose or YP-low
phosphate with 2% raffinose for 1 h at 27°C. Two ODs of the culture grown in
S with 2% raffinose were then induced with 1% galactose and labeled with
[35S]methionine (0.28 Ci/ml) for 4 h at 27°C. 2 ODs of the culture growing
in YP-low phosphate with 2% raffinose were simultaneously induced with 1%
galactose in the presence of [32P]orthophosphate (10 Ci/l) for 4 h at 27°C.
At the end of the incubation, the cultures were spun in glass tubes for 5 min
at 25°C. All samples were washed in Tris (10 mM), sodium azide (20 mM),
and sodium fluoride (20 mM) and then spheroplasted in spheroplast buffer
(100 mM Tris, 1.2 M sorbitol, 10 mM sodium azide, 0.015% -mercaptoetha-
nol, 0.1 mg/ml Zymolyse 100T) for 30 min at 37°C. Subsequently, samples
were spun in Eppendorf tubes for 5 min at 2000 rpm. The pellets were lysed
in 75 l of ice-cold 1 PBS and then boiled immediately in 2 boiling buffer
(2% SDS, 20 mM Tris, pH 8, 10 mM EDTA) for 5 min at 95°C. Samples were
diluted with 1 ml of IP buffer (10 mM Tris, pH 8, 150 mM NaCl, 0.5% Tween
20, 0.1 mM EDTA), and microfuged for 10 min at 4°C. Supernatants were then
removed, further diluted in IP buffer, and used for immunoprecipitations
with respective antibodies for 1 h on ice. For [32P]orthophosphate-labeled
cells, RNAse A (DNase, protease free; Sigma-Aldrich) was added to 30 g/ml
(1 l of enzyme/ml IP buffer) to reduce background on gels from radiolabeled
RNA contaminants. Immune complexes were pulled down with protein
A-Sepharose, washed with IP buffer, and IP buffer with 2 M urea and 1%
betamercaptoethanol before boiling in 100 l of SB. Samples were run on SDS
polyacrylamide gels, dried, and exposed to film.
RESULTS
KIN1 and KIN2 Are Potent Suppressors of Secretion-
defective Alleles of Rho3 and Cdc42
Rho3 is a member of the Rho family of GTPases that exhibits
multiple genetic and physical interactions with components
of the exocytic machinery and is itself required for efficient
exocytosis (Adamo et al., 1999; Robinson et al., 1999). To
isolate candidate downstream effectors of RHO3 function in
exocytosis, we performed a genetic screen for dosage sup-
pressors of the slow growth phenotype of a RHO3 deletion
strain (rho3). We constructed a strain containing the RHO3
coding sequence under the control of the glucose-repressible
GAL promoter as the only source of Rho3 in the cell. This
strain, which grows normally on galactose-containing media
but extremely slowly in glucose-containing media, was
transformed with a yeast genomic library prepared in a
multicopy vector, and transformants were selected for
growth on glucose-containing medium. Plasmids from col-
onies growing on glucose were isolated, retested for sup-
pression, and then analyzed by sequencing. From this anal-
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ysis, we identified 25 suppressing plasmids containing
overlapping parts of six distinct loci. Five of the six loci had
genes previously isolated as dosage suppressors of a rho3
mutant: BEM1 (1 isolate), SRO9 (1 isolate), SEC4 (2 isolates),
SSO2 (3 isolates), and RHO3 itself (17 isolates) (Imai et al.,
1996; Adamo et al., 1999). Subcloning of the various regions
in the sixth locus identified the suppressing gene to be
coincident with the KIN1 gene (Figure 1A). Although several
suppressors of rho3 (SEC4, SRO7, SRO77, SEC9, and SSO2)
are known components of the late secretory machinery, the
function of KIN1 is not known. The KIN1 open reading
frame alone was sufficient to suppress rho3, and thus we
identified KIN1 as a novel dosage suppressor of Rho3.
Mutations in RHO3 affect both actin organization and
post-Golgi vesicle transport (Imai et al., 1996; Adamo et al.,
1999). The rho3-V51 cold-sensitive mutant has a secretory
defect in the absence of functional and structural perturba-
tions of the actin cytoskeleton; hence, this mutant affects a
function of Rho3 in exocytosis that is independent of actin
(Adamo et al., 1999). To determine whether Kin1 functions
specifically in the secretory pathway downstream of Rho3,
we assessed the ability of KIN1 to suppress the rho3-V51
mutant. rho3-V51 is viable at 25°C, but not at 14°C. Figure 1B
shows that overexpression of KIN1 resulted in restoration of
growth of the rho3-V51 mutant at the restrictive temperature
(14°C). In addition, we have previously reported that the
growth defect of cdc42-6, the secretion-impaired mutant of
another Rho GTPase, is specifically suppressed by introduc-
tion of KIN1 on the multicopy plasmid (Adamo et al., 2001).
This suppression was specific to cdc42-6, because KIN1 failed
to suppress more pleiotropically defective alleles of CDC42
such as cdc42-1.
Because the coding sequence of KIN2 is similar to that of
KIN1 (51% identity), we asked whether they shared a com-
mon function downstream of Rho3 and Cdc42 by determin-
ing the ability of high-copy KIN2 to suppress the growth
Figure 1. Isolation of KIN1 as a suppressor of the RHO3 deletion (rho3). (A) Scheme shows genomic DNA fragments identified as
suppressors of the rho3 phenotype. Cells containing a single copy of the galactose-inducible RHO3 were transformed with a genomic library
on a high copy vector and cultured in the presence of 2% glucose to repress Rho3 expression. Plasmids from transformants exhibiting normal
growth in the absence of RHO3 were isolated and sequenced. The open reading frame of KIN1 alone was shown to be sufficient for the full
suppression of rho3. (B) KIN1 suppresses the cold sensitivity of the rho3-V51 mutant. The rho3-V51 mutant was transformed with KIN1 on
a multicopy plasmid, cultured on selective media at 25°C, replica plated from the microtiter plates to YPD media, and incubated at permissive
(25°C) and restrictive (14°C) temperatures.
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defects associated with rho3-V51 and cdc42-6 mutant strains.
As shown in Table 1, we found that KIN2 strongly sup-
pressed the growth defect of these mutants at their respec-
tive restrictive temperatures (14°C for rho3V-51 and 32°C for
cdc42-6), and the potency of KIN2 was identical to that of
KIN1. The fact that both kinases specifically suppress secre-
tory-defective alleles of Rho3 and Cdc42 suggests that both
KIN1 and KIN2 act in the secretory pathway downstream of
the Rho GTPases.
KIN1 and KIN2 Exhibit Genetic Interactions with
Components of the Late Secretory Machinery
The ability of KIN1 and KIN2 to suppress the cdc42-6 and
rho3-V51 alleles suggests a possible role for these kinases in
the regulation of exocytosis. To further explore this idea, we
examined the ability of multicopy KIN1 and KIN2 to sup-
press the temperature-sensitive growth defect of a number
of secretory (sec) mutants. An example of the suppression
analysis, summarized in Table 2, is shown in Figure 2.
Elevated dosage of KIN1 and KIN2 restored the growth of
the late sec mutants sec4-P48 and sec15-1 to wild-type levels
at 14 and 35°C, respectively (Figure 2). sec4-P48 is a cold-
sensitive effector domain mutant of the Rab GTPase SEC4
(Brennwald et al., 1994), whereas sec15-1 is a temperature-
sensitive mutant of one of the components of the Exocyst
complex, Sec15 (TerBush and Novick, 1995). We examined
the secretory defect in sec15-1 cells with multicopy KIN2
compared with control sec15-1 cells containing empty vector
after a shift to the restrictive temperature. This analysis
demonstrated that although unsuppressed sec15-1 cells are
found to accumulate 36% of BglII internally, the accumula-
tion is reduced to wild-type levels in sec15-1 cells containing
high-copy KIN2 where only 18% of BglII is found internally.
Therefore, the suppression of the growth defect was found
to correlate closely to suppression of the secretion defect in
these cells. Suppression analysis demonstrated that KIN1
and KIN2 also suppress the growth defect of a number of
other late secretory mutants. These include the temperature-
sensitive mutants of two additional components of the Exo-
cyst complex; Sec3 (sec3-2) and Sec10 (sec10-2), which were
rescued at the nonpermissive temperature of 35°C by intro-
duction of KIN1 and KIN2 on high copy. Also, we show that
expression of multicopy KIN1 and KIN2 restores the growth
of sec1-1 at 33°C and sec2-41 at 33°C. sec1-1 is a mutant of
SEC1, which is involved in SNARE assembly (Carr et al.,
1999), and sec2-41 is a mutant in SEC2, the nucleotide ex-
change factor for Sec4 (Walch-Solimena et al., 1997). Thus,
KIN1 and KIN2 exhibit strong genetic interactions with mul-
tiple components of the exocytic machinery. The suppres-
sion profile of KIN1 was identical to that of KIN2, providing
additional evidence in favor of the functional redundancy of
the two kinases (Table 4). The ability of KIN1 and KIN2 to
suppress several late sec mutant genes indicates that they
Table 1. KIN1 and KIN2 act redundantly in suppression of rho3-V51
and cdc42-6, secretion-impaired mutants of Rho GTPases
Mutant 2 KIN1 2 KIN2 2 vector
rho3-V51cs   —
cdc42-6ts   —
rho3-V51 and cdc42-6 mutants were transformed with either vector
(pRS426), KIN1, or KIN2 on high copy, cultured on selective me-
dium at room temperature, and replica plated from the microtiter
plates to YP-D media. Growth of transformants at mutant’s restric-
tive temperatures, 14° C for rho3-V51 and 32° C for cdc42-6, was
tested. Scoring reflects the colony growth at restrictive temperatures
relative to the wild-type yeast () and to the empty vector
control (—).
Table 2. Summary of late sec mutants suppression by KIN1 and
KIN2











Late acting sec mutants were transformed with either vector
(pRS426), KIN1, or KIN2 on high copy. Growth of transformants at
restrictive temperatures was tested. sec mutants restrictive temper-
atures are as follows: 33°C for sec1-1, 33°C for sec2-41, 35°C for
sec3-2, 14°C for sec4-P48, 33°C for sec5-24, 35°C for sec6-4, 37°C for
sec8-9, 34°C for sec9-4, 35°C for sec10-2, and 35°C for sec15-1. Scoring
reflects the mutant colony growth at their respective restrictive
temperatures relative to the wild-type yeast () and empty
vector control (—). Suppression of the sec mutants is indicated as
follows: , very strong; , strong; , moderate; and /,
weak.
Figure 2. KIN1 and KIN2 suppress late secretory mutants. KIN1
and KIN2 suppress the cold sensitivity of the sec4-P48 mutant (A)
and the temperature sensitivity of the sec15-1 mutant (B). Mutants
were transformed with KIN1 and KIN2 on high copy plasmids,
cultured on selective media at 25°C, replica plated from the micro-
titer plates to YPD media, and incubated at restrictive (14°C for
sec4-P48 and 35°C for sec15-1) and permissive (25°C) temperatures.
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function downstream of these proteins at the later stage of
exocytosis.
However, we found that KIN1 and KIN2 do not suppress
the temperature-sensitive phenotype of the sec9-4 mutant
(Table 2), a mutant of the t-SNARE Sec9 that is defective in
SNARE complex assembly and that is required for vesicle
fusion with the plasma membrane (Rossi et al., 1997), nor do
they suppress the growth defect of sro7/77, a mutant with
a double disruption of genes encoding Sec9-binding proteins
Sro7 and Sro77 (Table 4). These observations place Kin1 and
Kin2 function downstream of polarized vesicle delivery and
upstream of the terminal fusion event.
Analysis of the Structural Requirements for KIN1 and
KIN2 Function in the Secretory Pathway
To elucidate the nature of Kin1 and Kin2 function in the
secretory pathway, we determined the minimal domain re-
quirement that confers suppression. Kin1 and Kin2 contain a
kinase domain at the N terminus of the protein and a reg-
ulatory domain at the C terminus (Figure 3A). The kinase
domain as well as the 42-amino acid stretch on the extreme
carboxy terminus are highly conserved between Kin1 and
Kin2 and a number of their orthologues from other species.
Because Kin1 and Kin2 proteins display structural and func-
tional redundancy, we focused on Kin2. Mutant KIN2 con-
structs with deletions of the kinase domain or the 42 amino
acid C-terminal tail were designed to assess the significance
of these domains for Kin2 function in the secretory pathway.
The following mutants were generated: KIN2-NT, lacking
the regulatory C-terminal domain of the protein; kin2-CT,
lacking the catalytic N-terminal domain; kin2-KD, the ki-
nase-dead mutant, where a single critical Lys128 residue in
the second catalytic domain (conserved residue mapped by
kinase sequences alignment; Hanks et al., 1988) was mutated
to a Met; and finally the KIN2-42 mutant, with a deletion of
the conserved 42 amino acid C-terminal tail (Figure 3A).
Function was assayed by analysis of the suppression
properties of the KIN2 mutants expressed at high copy. The
suppression of the mutant phenotype of several late sec
genes was tested, including sec15-1 and sec4-P48, sec1-1,
sec2-41, and sec10-2 (Figure 3B). Wild-type KIN2 on a mul-
ticopy plasmid behaved as reported above (Figure 2 and
Table 2), restoring the viability of these mutants at certain
restrictive temperatures. The kinase-inactive KIN2 mutants
kin2-CT, lacking the entire kinase domain, and kin2-KD, the
kinase-dead mutant, failed to suppress the growth defect of
all sec mutants tested (Figure 3B). These data demonstrate
that the catalytic activity of Kin2 is critical for its function in
the secretory pathway.
Multicopy expression of KIN2-NT, lacking the entire C-
terminal domain, and KIN2-42, lacking the 42 amino acid
C-terminal tail, rescued the growth phenotype of all late sec
mutants tested: sec15-1, sec4-P48, sec1-1, sec2-41, and sec10-2
(Figure 3B). Thus, the regulatory domain of Kin2 is func-
tionally dispensable. Furthermore, we observed that the
KIN2-NT and KIN2-42 mutants at high copy gain the abil-
ity to suppress several secretory mutants: sec1-1, sec2-41, and
sec10-2, at temperatures at which the wild-type KIN2 failed
to suppress (Figure 3B). The sec1-1 and sec2-41 temperature-
sensitive mutants are suppressed at 33°C and the sec10-2
mutant at 35°C in a comparable manner by KIN2, KIN2-NT,
and KIN2-42 (our unpublished data). However, KIN2 fails
to suppress sec1-1 at 35°C and sec2-41 and sec10-2 at 37°C,
whereas the KIN2-NT mutant with the deletion of the regu-
latory domain is able to rescue these mutants at the more
restrictive temperatures. Remarkably, the truncation of the
distal 42 amino acids at the C terminus of KIN2, in KIN2-42,
is sufficient to phenocopy the gain of function observed by
KIN2-NT. Both mutant forms of KIN2 are capable of sup-
pressing sec1-1 at 35°C and sec2-41 and sec10-2 at 37°C (Fig-
ure 3B). These data demonstrate that the C-terminal nonki-
nase domain of Kin2 acts as a negative regulator of Kin2
function in the secretory pathway and that the conserved
42-amino acid tail is essential for this negative regulatory
function.
The greater potency of the Kin2 constructs lacking the
distal C-terminal sequence might reflect the acquisition of
the catalytically “active” protein conformation in the ab-
sence of the putatively inhibitory C-terminal tail. Possibly, in
a dormant state the wild-type kinase exists in a closed con-
formation, with the tail bound to the catalytic core, hinder-
ing its activity, until the “ON” regulatory event relieves this
autoinhibition (Figure 3C). This hypothesis presupposes the
presence of a direct physical interaction between the tail of
Kin2 and its kinase domain. To test whether this intramo-
lecular interaction takes place, we used a yeast two-hybrid
analysis. We created the following constructs: Kin2-CT and
Kin2-CT42 (encoding the regulatory domain with and
without the C-terminal tail region, respectively) as GAL4
binding domain fusions and Kin2 (full-length protein),
Kin2-NT (kinase domain), Kin2-CT (regulatory domain),
Kin2-CT42 (regulatory domain with the deletion of the
C-terminal 42 amino acids) and Kin2-42 (full-length pro-
tein with the deletion of C-terminal 42 amino acids) as GAL4
activation domain fusions. All constructs in activation and
binding domain fusions were expressed at comparable lev-
els as verified by Western blot analysis (our unpublished
data). We found that the C-terminal regulatory domain of
Kin2 (Kin2-CT in GAL4BD) binds to the catalytic N-terminal
domain of Kin2 (Kin2-NT in GAL4AD) (Table 3). Moreover,
this interaction is mediated by the conserved 42 amino acid
tail, because it is abolished by truncation of the tail region in
the C-terminal domain of Kin2: Kin2-CT42 does not bind to
Kin2-NT. Kin2-CT does not interact with itself, which is
consistent with the regulatory domain interacting with the
kinase domain only. In addition, although Kin2-CT fails to
interact with the full-length Kin2, it shows interaction with
the C-terminally truncated Kin2 Kin2-42 (lacking the distal
42 amino acids). This result may signify that Kin2-CT asso-
ciates with Kin2 in a presumably “open” or active confor-
mation, as in Kin2-42, but not with Kin2 in a closed con-
formation, as in full-length kinase. Thus, yeast two-hybrid
analysis revealed that the regulatory domain of Kin2 binds
to its catalytic domain and that the 42-amino acid tail is a
prerequisite for this interaction. To further support the pos-
sible interaction of the Kin1/2 kinase domain with the C-
terminal domain, we examined the ability of the domains to
interact in vitro. We made use of a recombinant GST-fusion
of the kinase domain and in vitro-translated C-terminal
domain fragments containing either the intact C terminus,
Kin2-CT(523–1147), or an identical domain lacking the con-
served C-terminal 42 amino acids, Kin2-CT42(523–1106).
The results shown in Figure 3C demonstrate that these do-
mains do in fact interact and that this interaction requires the
C-teminal 42 residues of the Kin2. Together, the in vitro
binding data and the two-hybrid analysis strongly suggest
that the C-terminal regulatory domain of Kin2 physically
interacts with the N-terminal kinase domain to mediate an
autoinhibitory regulation of the kinase. Furthermore, we
show that the highly conserved 42-amino acid tail of Kin2 is
critical for the both the physical interaction between these
domains and for the negative regulatory effect of the C-
terminal domain as demonstrated by the effects on suppres-
sion of the late sec mutants. Together, this strongly suggests
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Figure 3. Analysis of the structural requirements for suppression of the secretory mutants by KIN2. (A) Schematic representation of the
structure of Kin2 (conserved regions are indicated in red) and Kin2 mutants. Five constructs were examined. KIN2, wild-type; KIN2-NT, a
mutant lacking the C-terminal domain; kin2-CT, a mutant lacking the kinase domain; kin2-KD, a kinase-dead mutant with a lysine to
methionine substitution at residue 128 (the asterisk indicates the position of the point mutation); and KIN2-42, a mutant with a deletion of
the conserved 42-amino acid C-terminal tail. (B) Suppression assays show that the catalytic activity of Kin2 is essential for its function and
that the conserved 42-amino acid tail plays a role in autoinhibition. Constructs described above along with the high copy vector control were
transformed into sec4-P48, sec15-1, sec1-1, sec2-41, and sec10-2 mutant strains, plated on YP-D media and cultured at permissive (25°C) and
their respective restrictive temperatures. kin2-KD and kin2-CT failed to suppress the growth defect of all sec mutants tested. KIN2-42 and
KIN2-NT exhibited suppression of sec1-1 at 35°C and sec2-41 and sec10-2 at 37°C, whereas KIN2 suppresses these mutants at 33°C only. (C)
In vitro binding of Kin2 C terminus to the N-terminal Kin2 kinase domain demonstrates an intramolecular interaction that depends on the
42-amino acid tail. Kin2-CT or Kin2-CT42 proteins (as shown in A) were in vitro translated in reticulocyte lysates and bound to GST fusion
proteins immobilized on glutathione agarose beads. After binding, beads were washed, and the bound fraction was boiled in sample buffer
and analyzed by SDS-PAGE and autoradiography. Input lane represents 10% of the radiolabeled protein. (D) Diagram depicting the proposed
autoinhibitory intramolecular interaction between the N- and C-terminal domains of Par-1 family kinases.
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that C-terminal domain of Kin1/2 functions as an autoin-
hibitory domain and that this autoinhibition requires the
highly conserved C-terminal 42 amino acids. This provides
the first mechanistic insight into to the function of this
highly conserved 42-residue sequence at the C terminus of
all Par-1 family kinases.
The Kinase Domain of SNF1, but Not Other Kinases of
the CaMK Group, Show Suppression Properties of the
Kin1 and Kin2 Kinases
It was previously reported that deletion of either KIN1 or
KIN2 is neither lethal nor deleterious for cell growth (Lamb
et al., 1991; Donovan et al., 1994). Because our data demon-
strated functional redundancy of KIN1 and KIN2, we pro-
ceeded to analyze whether the presence of at least one of
these genes is required for cell viability. We created strains
carrying single or double disruptions of these genes by
homologous recombination. Consistent with the previous
reports, kin1 and kin2 single disruptant strains were via-
ble. The double disruptant kin1, kin2 progeny, obtained
by crossing of the kin1 strain with kin2, demonstrate
normal growth at all temperatures tested (25, 14, and 37°C).
The single, kin1 and kin2, and double kin1, kin2 dis-
ruptants did not exhibit any significant defects in growth or
secretion, as confirmed by invertase secretion assays (our
unpublished data).
KIN1 and KIN2 orthologues in S. pombe, C. elegans, D.
melanogaster, and mammalian cells display pronounced gene
disruption phenotypes. Hence, it is likely that in S. cerevisiae
anther molecule(s) acts to substitute the compromised func-
tion of Kin1 and Kin2. Kin1 and Kin2 belong to the CaMK
protein kinase group, members of which share significant
sequence similarity in the catalytic domain. Therefore, we
examined whether other kinases of this group display func-
tional redundancy with Kin1 and Kin2. BLAST search was
used to identify the closest homologues of Kin1 and Kin2,
and, as a result, we considered seven proteins of the CaMK
group for further analysis, including Snf1, Hsl1, Gin4, Kcc4,
Ypl141c, Kin4, and Ypl150w. To determine whether these
proteins act in the secretory pathway, we tested their ability
to rescue the growth defect of sec2-41, sec10-2, and sec15-1.
Because several members of the CaMK group, such as Hsl1,
Gin4, and Kcc4 bear a sequence at the distal carboxyl tail
almost identical to that of Kin1 and Kin2, we hypothesized
that they might be subjected to a similar mode of autoreg-
ulation as Kin2. To overcome this possible autoinhibition,
we generated deletion constructs of SNF1 (encoding amino
acids 1–432), HSL1 (1–462), GIN4 (1–432), KCC4 (1–437),
YPL141C (1–387), KIN4 (1–366), and YPL150W (1–426),
which lack the regulatory domain while preserving intact all
regions important for catalytic activity based on sequence
alignment. These constructs were introduced on a multicopy
plasmid into sec15-1, sec10-2, and sec2-2 mutants and incu-
bated at permissive and nonpermissive temperatures. We
show that the catalytic domain of SNF1 (SNF1-NT) sup-
presses the growth defect of sec15-1, sec10-2, and sec2-2 mu-
tants (Figure 4). Furthermore, the suppression of sec mutants
by SNF1-NT is comparable to that of KIN2-NT. By contrast,
constructs encoding the catalytic domains of Hsl1, Gin4,
Kcc4, Ypl141C, Kin4, and Ypl150W failed to restore growth
of the sec mutants at restrictive temperatures to any signif-
icant degree. Our data demonstrate that Snf1, which is struc-
turally closer to Kin1 and Kin2 than any of the other seven
members of the CaMK group, is the only kinase, out of those
tested that may function redundantly with Kin1 and Kin2 in
exocytosis.
To test whether the function of at least one of these genes,
KIN1, KIN2, or SNF1, is essential for cell viability, we gen-
erated the strain with a triple disruption, kin1, kin2, snf1.
kin1, kin2, snf1 was created by substitution of SNF1 with
the KanR (Kanamycin) gene sequence in the context of the
diploid strain homozygous for the KIN1 deletion (kin1) and
heterozygous for the KIN2 deletion (kin2). A triple dis-
ruptant was obtained via sporulation and tetrad analysis.
The triple mutant kin1, kin2, snf1 as well as the double
kin1, snf1, and kin2, snf1 mutants displayed slow
growth phenotype inherent to the SNF1 deletion alone
(Celenza and Carlson, 1984). The kin1, kin2, snf1 triple
mutant did not display any synthetic defect in growth or
secretion (as verified by invertase secretion assays; our un-
published data).
Kin1 and Kin2 Physically Associate with Components of
the Late Exocytic Machinery
Because genetic data place Kin1 and Kin2 function to the late
secretory pathway, we analyzed whether these proteins
physically associate with any of the components of the exo-
cytic machinery.
Initially, we generated antibodies to detect Kin1 and Kin2
and characterized their localization in budding yeast. Anti-
bodies were raised against a region in the C-terminal do-
main of Kin1 and Kin2. Affinity-purified antisera were tested
by Western blot analyses on samples containing either high
copy KIN1 and KIN2 or empty vector (Figure 5A). Kin1 and
Kin2 antisera specifically recognized each protein and did
not cross-react with the other gene product, with both pro-
teins running on SDS-PAGE at 145 kDa as predicted by the
Table 3. Yeast two-hybrid analysis shows that C-terminal 42 amino
acid tail of Kin2 is necessary for the interaction of the regulatory
C-terminal domain of Kin2 with the kinase domain
Growth on
BD-fusions AD-fusions trp/leu ade












GAL4BD-Kin2-CT (amino acids 521–1147) and GAL4BD-Kin2-
CT42 (521–1106) constructs were tested against GAL4AD-Kin2,
GAL4AD-Kin2-NT (1–526), GAL4AD-Kin2-CT (521–1147),
GAL4AD-Kin2-CT42 (521–1106), and GAL4AD-Kin2-42 (1–1106)
constructs and vector containing GAL4AD alone (where GAL4BD is
GAL4 binding domain vector; GAL4AD is GAL4 activation domain
vector). Constructs were transformed into PJ694 strain, the pres-
ence of both activation and binding domain plasmids was con-
firmed by culturing on the selective medium (trp/leu), and an
interaction was assayed by replica plating of six different colonies
onto the medium lacking adenine (ade). Protein expression was
verified by Western blot analysis (our unpublished data). The full-
length C-terminal domain of Kin2 in BD (GAL4BD-Kin2-CT) asso-
ciates with AD-Kin2NT and AD-Kin2-42 exclusively, and this
association is abolished upon truncation of terminal 42 amino acids
in GAL4BD-Kin2-CT42.
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estimated molecular weight (Lamb et al., 1991; Donovan et
al., 1994). Next, we analyzed the intracellular distribution of
Kin1 and Kin2 by cell fractionation. Lysates from cells over-
expressing Kin1 or Kin2 were treated with or without Triton
X-100 and centrifuged at 30,000  g. Supernatant and pellet
fractions obtained were analyzed by SDS-PAGE and West-
ern blot with anti-Kin1, anti-Kin2, and anti-Sso1/2 (as an
internal control) antibodies (Figure 5B). We determined that
70% of both Kin1 and Kin2 occur in the supernatant or
cytosolic fraction (precisely 71.5% of Kin1 and 73.7% of Kin2
as an average of 3 or more experiments), and the remaining
30% is found in the pellet or membrane-bound fraction.
Therefore, consistent with the previous report (Tibbetts et al.,
1994), Kin1 and Kin2 partition to both cytosolic and mem-
brane-associated pools in S. cerevisiae.
Genetic data suggest that Kin1 and Kin2 act down-
stream of Rho3, Cdc42, Sec4, and components of the Exo-
cyst complex but upstream of the t-SNARE Sec9 and the
Sec9-binding protein Sro7. Therefore, we hypothesized
that Kin1 and Kin2 interact and function together with
proteins important for the final stages of exocytosis, such
as the SNAREs. To test this, we used the candidate ap-
proach to search for Kin1- and Kin2-interacting partners.
First, we observed that antibodies against both Kin1 and
Kin2 bring down the t-SNARE Sec9 when both genes are
expressed at high copy (Figure 6A). Sec9 immunoprecipi-
tation with Kin1 and Kin2 antibodies was detected with
the endogenous levels of Kin1 and Kin2 as well (our
unpublished data). To confirm that Kin1 exists in a pro-
tein complex with Sec9 by a different method, we used a
chemical cross-linking procedure. Cells from strains over-
expressing both KIN1 and SEC9 were labeled with
[35S]methionine for 1 h and then lysed. Lysed cells were
treated with the chemical cross-linker DSP and subjected
to two rounds of immunoprecipitation. In the first round,
samples were divided into two pools and incubated with
affinity-purified antibodies either against Kin1 or against
Sec9, and immune complexes formed were pulled down
via protein A-Sepharose. In the second round, each of the
two pools was subjected to a denaturing immunoprecipi-
tation with either anti-Sec9 or anti-Kin1 antibodies. Our
results show that in the presence of the cross-linker Kin1
coimmunoprecipitates Sec9, and in its turn, Sec9 pulls
down Kin1 (Figure 6B).
To identify other potential Kin1- and Kin2-interacting
partners, we performed a series of native immunoprecipita-
tion experiments testing for the association of Kin1 and Kin2
with proteins acting in the secretory pathway. Namely, we
examined whether antibodies against Kin2 can pull down
two other exocytic SNAREs, Sso and Snc, the Sec9-interact-
ing protein Sro7, and the Rab GTPase Sec4. Kin2 was im-
munoprecipitated from the cell lysates carrying multicopy
KIN2, and the sample was analyzed by Western blotting
with -Kin2, -Sso2, -Snc1, -Sro7, and -Sec4 antibodies,
respectively. This experiment revealed that the -Kin2 anti-
body brings down significant amounts of Sro7, a homologue
of a tumor suppressor protein lethal giant larvae (Lgl), but
not other proteins tested (Figure 6C). As expected, Sro7 also
coimmunoprecipitates with anti-Kin1 antibodies (our un-
published data). Therefore, Kin1 and Kin2 associate with
t-SNARE Sec9 and the Sec9-binding protein Sro7.
To determine whether association of Kin1 and Kin2 with
Sec9 and Sro7 is a result of a direct binding between these
proteins, we used a yeast two-hybrid analysis. Kin1 and
Kin2 in both GAL4 binding and GAL4 activation domain
fusions did not show interaction with either Sec9 or Sro7 in
GAL4 activation and GAL4 binding fusions, respectively
(our unpublished data). This indicates that the interaction of
Kin1 and Kin2 with Sec9 and Sro7 is not direct but occurs via
other intermediaries in the complex.
The physical association of Kin1 and Kin2 with the
SNARE machinery supports the hypothesis that these Par-1
counterparts play a role in exocytosis at a stage between
vesicle docking site recognition and fusion with the plasma
membrane.
Kin1 and Kin2 Induce Phosphorylation of Sec9 In Vivo
and Its Release from the Plasma Membrane to the
Cytosol
Next, we focused on finding a downstream target of Kin1
and Kin2 function in the exocytic pathway. We observed
that the interaction partner of Kin1 and Kin2, the t-SNARE
Sec9, undergoes a size shift upon transient overexpression of
the catalytically active Kin2 kinase (Figure 7A). Overexpres-
Figure 4. The catalytic domain of SNF1, but not of other kinases belonging to the Snf1 family, suppresses the same set of late secretory
mutants as KIN1 and KIN2. The sec15-1, sec10-2, and sec2-41 mutants were transformed with either vector alone or the respective catalytic
domains of KIN2 (encoding residues 1–526), SNF1 (1–432), HSLl1 (1–462), GIN4 (1–432), KCC4 (1–437), YPL141c (1–387), KIN4 (1–366), and
YPL150w (1–426) on high copy plasmids. Growth of transformants at respective restrictive temperatures was tested.
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sion of Kin1 gave a similar shift in Sec9 mobility but induc-
tion of the kinase-dead mutants of Kin1 and Kin2 failed to
induce any detectable shift in Sec9 (our unpublished data).
To test whether this shift is indeed the result of phosphor-
ylation, we analyzed the effect of phosphatase treatment on
the mobility of immunoprecipitated Sec9 protein after Kin2
induction. Cells carrying either vector alone or CEN/GAL
KIN2 were incubated in galactose-containing medium for
4 h to induce Kin2 expression, and lysates obtained from
these cells were subjected to immunoprecipitation with anti-
Sec9 antibodies. Sec9-containing immune complexes were
subsequently treated with two different phosphatases:
-phosphatase or CIP. Phosphatase treatment, but not mock
control treatment, abolished the Kin2-dependent size shift of
Sec9, demonstrating that the change in Sec9 mobility in
response to Kin2 induction is indeed due to phosphorylation
(Figure 7A).
We next examined whether Sec9 is phosphorylated di-
rectly by Kin1/Kin2 in vitro. We made use of recombinant
Sec9 protein as a substrate in an in vitro kinase reaction and
looked for [-32P]ATP incorporation in the presence of im-
munoprecipitated Kin1/Kin2 proteins bound to protein A-
Sepharose beads. The data shown represent phosphoryla-
tion reactions in the presence of Kin2; however, we found
Figure 5. Kin1 and Kin2 proteins are found in both cytosolic and membrane-bound pools. (A) Affinity-purified antibodies against the
C-terminal domains of Kin1 and Kin2 recognize proteins in a specific manner, running at 145 kDa on SDS-PAGE. Wild-type cells and cells
containing either KIN1 or KIN2 on high copy were subjected to 7% SDS-PAGE and Western blot by using affinity-purified antibodies against
Kin1 and Kin2. (B) Kin1 and Kin2 are found in both the cytosolic and membrane-bound pools. Lysates from cells containing either vector
alone, KIN1, or KIN2 on high copy were treated with or without Triton X-100 and centrifuged at 30,000  g for 15 min. Supernatant and pellet
fractions were analyzed (T, total; S30, supernatant; P30, pellet) by SDS-PAGE (pellet fractions were resuspended in the volume equal to that
of S30 fraction) and blotted with anti-Kin1 and anti-Kin2 antibodies. Approximately 70% of both Kin1 and Kin2 is seen in the cytosolic fraction
and 30% is in a Triton-sensitive membrane fraction. Samples also were immunoblotted with anti-Sso1/2 polyclonal antibody as an internal
control of the fractionation procedure (consistent with previous reports 80% of Sso1/2 was detected in the pellet fraction).
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Figure 6. Kin1 and Kin2 physically associate with the t-SNARE Sec9 and the Sec9-binding protein Sro7. (A) Antibodies against Kin1 and Kin2
coimmunoprecipitate Sec9. Cell lysates carrying either high copy KIN1 and SEC9 or high copy KIN2 and SEC9 were subjected to native
immunoprecipitation with preimmune serum (PI) and either anti-Kin1 or anti-Kin2 antibodies (I), respectively, as described in Materials and
Methods. Samples were separated on 8% SDS-PAGE and immunoblotted with anti-Sec9 and either anti-Kin1 or anti-Kin2 antibodies, respectively.
“T” stands for total protein in the lysate before IP, loaded at 1:20 to the amount of lysate used to immunoprecipitate Kin1 and Kin2 in PI and I lanes.
(B) Cross-linking experiment confirms association between Kin1 and Sec9. Cells expressing SEC9 and KIN1 on a multicopy plasmid were
35S-labeled for 1 h and lysed osmotically in PBS. Lysates were subjected to cross-linking, followed by two rounds of immunoprecipitations, initially
with -Kin1 and -Sec9 antibodies, followed by a denaturing IP with -Kin1 and -Sec9 antibodies. Samples were run on 7% SDS-PAGE, and the
35S-labeled protein was detected by autoradiography. (C) Kin2 coassociates with Sro7, but not with Snc1, Sso2, or Sec4. Lysates from cells
transformed with high copy KIN2 were subjected to native immunoprecipitation with preimmune serum (PI) and -Kin2 antibody (I) as described
in Materials and Methods, followed by SDS-PAGE and immunoblot with -Kin2, -Sro7, -Snc1, -Sso2, and -Sec4 antibodies.
M. Elbert et al.
Molecular Biology of the Cell542
Figure 7. The t-SNARE Sec9 is phosphorylated as an effect of Kin1 or Kin2 induction. (A) Sec9 undergoes a phosphorylation-dependent size shift in
response to Kin2 induction. Lysates from galactose-induced yeast cells containing high copy Sec9 and either a CEN/GAL vector or CEN/GAL-KIN2 were
immunoprecipitated with anti-Sec9 antibody. Immune complexes were treated with -phosphatase and CIP for 30 min at 30 and 37°C, respectively.
Untreated and mock-treated samples, incubated under identical conditions, were used as a control. Samples were subjected to 8% SDS-PAGE and
immunoblotted with -Sec9 antibody. (B) N terminus of Sec9 is a substrate of Kin2 in vitro. Cells expressing Kin2 were subjected to immunoprecipitation
with either -Kin2 antibody (I) or preimmune serum (PI) as a negative control. Immobilized Kin2 on protein A-Sepharose beads was used for in vitro
kinase assays. Equal molar amounts (1.5 M) of soluble recombinant Sec9-NT1 (amino acids 1–168), Sec9-NT2 (amino acids 166–401), and Sec9-CT (amino
acids 402–651) were added to the reaction and incubated with [32P]ATP for 30 min at 30°C. Samples were analyzed by SDS-PAGE and autoradiography
(1). In 2, wild-type Sec9-NT2 and Sec9-NT2-S315A mutant were tested in an in vitro kinase reaction as described above. Concentrations of recombinant
proteins used in the kinase reaction were measured by a Bradford protein assay, normalized to equal concentrations, and verified by Coomassie staining.
(C) Sec9 is not a direct target of Kin2 in vivo. Lysates from cells containing CEN/GAL vector or CEN/GAL Kin2 containing multicopy wild-type Sec9 or
mutant Sec9-S315A were induced with galactose for 4 h. Cells were then spheroplasted and lysed, and the lysates were boiled and separated by
SDS-PAGE and immunoblotted with anti-Sec9. Arrows indicate Sec9 mobility shift.
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virtually identical results for immunoprecipitated Kin1 in
these assays. The recombinant Sec9 protein was initially
divided into three domains, Sec9-NT1 (amino acids 1–168),
Sec9-NT2 (amino acids 166–401), and Sec9-CT (correspond-
ing to the SNAP25 domain amino acids 401–651), each of
which were fused to GST, expressed in bacteria, and purified
as described previously (Rossi et al., 1997). This analysis
demonstrated that the Sec9-NT2 protein turned out to be an
excellent substrate for Kin2 (Figure 7B, 1), with phosphoac-
ceptor activity significantly greater than that of casein,
which was previously identified as a test substrate of Kin1
and Kin2 in vitro (Lamb et al., 1991; Donovan et al., 1994). We
subsequently mapped the site of Sec9 phosphorylation by
Kin2 to serine 315 by sequential deletion and mutagenesis of
serine or threonine residues to alanine. In particular, we
found that the substitution of serine 315 to alanine abolished
the ability of Kin2 to phosphorylate Sec9-NT2 in vitro (Fig-
ure 7B, 2). We used the same strategy to map a significantly
weaker in vitro phosphoacceptor site in the SNAP-25 do-
main of Sec9 to serine 632 (our unpublished data). We next
determined the effect of the mutation of these sites on the
Kin2-induced phosphorylation of Sec9 in vivo. Surprisingly,
we found that the Sec9-S315A as well as Sec9-S315A, S632A
proteins were identical to wild-type Sec9 in the Kin2 in-
duced phosphorylation as judged by a mobility shift (Figure
7C). Therefore, the major phosphoacceptor sites on Sec9
phosphorylated by Kin2 in vitro are not responsible for
Kin2-induced phosphorylation of Sec9 in vivo. This result
indicates that in vivo Kin1/Kin2 are unlikely to directly
phosphorylate Sec9, but rather this phosphorylation occurs
as a downstream effect of Kin1/Kin2 induction, presumably
by direct or indirect activation of a kinase, which in turn
phosphorylates Sec9 at a site or sites other than serine 315.
To assess the specificity of the catalytic activity of Kin1
and Kin2, we examined whether other components of the
late exocytic machinery are phosphorylated by these ki-
nases. In vivo experiments were performed on cells carrying
either vector alone or CEN/GAL KIN2, radioactively labeled
with [32P]orthophosphate during a 4-h induction of Kin2 in
galactose-containing medium. Lysates from these cells were
immunoprecipitated with antibodies against Sec9, Sso1/2,
Sro7, and a number of components of the Exocyst complex
and a subset of small GTPases involved in secretion. An
identical set of strains was simultaneously labeled with
[35S]methionine to control for the presence of the proteins in
the lysates examined. Proteins were separated on SDS-
PAGE, and their phosphorylation state was determined by
autoradiography. Out of all proteins tested, only Sec9 dis-
played an increased level of [32P]orthophosphate incorpora-
tion in cells overexpressing Kin2 (Figure 8). Thus, Kin2
specifically induces the phosphorylation of Sec9. These data
allow us to hypothesize that Kin1 and Kin2 act in the secre-
tory pathway by regulating the phosphorylation of the t-
SNARE Sec9.
To address the functional significance of the Sec9 phos-
phorylation induced by Kin1 and Kin2, we tested whether
expression of these kinases affects the subcellular localiza-
tion of Sec9. We analyzed the distribution of Sec9 into pellet
and supernatant fractions after centrifugation at 30,000  g
in galactose-induced and uninduced cells carrying CEN/
GAL KIN1. In uninduced cells (as well as in cells carrying
empty CEN/GAL vector; our unpublished data) 50–60% of
Sec9 is cytosolic and partitions into the supernatant fraction,
whereas the rest is membrane bound (the Triton-sensitive
pellet fraction) (Figure 9). Interestingly, in cells expressing
CEN/GAL KIN1 the proportion of the cytosolic Sec9 is in-
creased relative to the membrane-bound Sec9 (Figure 9).
Averaging three independent experiments, induction of
Kin1 expression resulted in reproducible elevation of the
cytosolic Sec9 levels to 70–75% of the total Sec9 pool. As
expected, Kin1 does not alter distribution of Sso1/2 under
identical conditions (Figure 9). Furthermore, Sec9 undergoes
a Kin1-mediated mobility shift exclusively in the cytosolic
but not the membrane fraction. As expected, induction of
KIN2 had the same effect on Sec9 distribution (our unpub-
lished data). Thus, overexpression of Kin1 or Kin2 results in
release of a fraction of Sec9 from the plasma membrane into
the cytosol.
To determine the effect of GAL-induced Kin1 overexpres-
sion on overall growth and secretory function, we examined
the ability of sec1-1 cells transformed with a GAL-KIN1 con-
struct to grow and secrete the periplasmic protein BglII. As
shown in Figure 9B, we find that galactose-induced expres-
sion of Kin1 protein results in dramatic suppression of the
growth defect at the nonpermissive temperature of 33°C.
Suppression by GAL-KIN1 is lost when the cells are grown
on noninducing YPD media. We examined the ability of
galactose induced sec1-1 transformants to secrete BglII after
a shift to restrictive temperature. As shown in Figure 9C, we
Figure 8. Sec9 is the only component of the exocytic apparatus
tested that is phosphorylated upon Kin2 induction. Cells containing
empty vector, or GAL-KIN2 were induced with galactose for 2 h
before labeling with either [35S]methionine or [32P]orthophosphate.
Denatured cell lysates were prepared and immunoprecipitated with
antibodies to the components of the late secretory machinery. Phos-
phate-incorporation was detected by SDS-PAGE and autoradiogra-
phy. Quantitation demonstrated that the when cells were induced
with GAL-KIN2, the amount of 32P label incorporated into Sec9
increased threefold. The small increase in 32P labeling in the cells
lacking GAL-KIN2 was due to slight increase in overall 32P labeling
in this sample.
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find that control sec1-1 cells containing an empty GAL vector
show an accumulation of internal BglII. In contrast cells
containing GAL-KIN1 show a dramatic suppression of the
secretory defect to levels of internal BglII found in wild-type
yeast cells. Therefore, the same conditions of Kin1 overex-
pression that result in a reduction of Sec9 levels on the
membrane also yield an overall “gain of function” in the
secretory pathway.
Based on these data, we suggest that the positive effect of
Kin1 and Kin2 on the secretory pathway may be mediated
through regulation of the plasma membrane t-SNARE Sec9.
Consistent with this assumption, overexpression of SEC9
suppresses growth defects of a number of late sec mutants
that also are suppressed by introduction of multicopy KIN1
and KIN2. High copy SEC9 is known to restore the viability
of rho3, sec4-P48, sec1-1, sec3-2, sec8-9, sec9-4, and sec15-1
Figure 9. Kin1 overexpression reduces the membrane association of Sec9 while increasing secretory function. (A) Fractionation of Sec9 in
GAL-KIN1 induced cells. Lysates from galactose-induced and uninduced cells containing CEN/GAL KIN1 and high copy SEC9 were treated
with or without Triton X-100 and centrifuged at 30,000  g for 15 min. Supernatant and pellet fractions were subjected to SDS-PAGE and
blotted with anti-Sec9 antibodies (T, total; S30, 30k  g supernatant; P30, 30k  g pellet). The proportion of Sec9 in the cytosolic and
Triton-sensitive membrane fraction was quantified as an average of three independent experiments. Samples also were immunoblotted with
anti-Sso1/2 polyclonal antibody as an internal control. (B) Suppression of the sec1-1 growth defect by GAL-KIN1. sec1-1 mutants were
transformed with empty vector or GAL-KIN1 and replicated for growth at permissive (25°C) and restrictive (33°C) temperatures on media
that induces (YP-Gal) or represses (YPD) overexpression of the Kin1 protein. (C) Suppression of the sec1-1 secretion defect by GAL-KIN1.
sec1-1 mutant strains containing empty vector or GAL-KIN2 were induced for 2 h in galactose, shifted to 33°C for 2 h, and then processed for
BglII secretion (defects in secretion are seen as an increase in the fraction of BglII found internally).
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(Lehman et al., 1999). When we compared the relative sup-
pression capabilities of high copy KIN1, KIN2, and SEC9, we
found that KIN1 and KIN2 largely mimic the SEC9 suppres-
sion profile and exert an effect either equal or less potent in
comparison with that of SEC9 (Table 4). The only mutant
that KIN1 and KIN2, but not SEC9, are capable of suppress-
ing is sec2-41, the significance of which remains to be ad-
dressed. Together, our results are consistent with Kin1 and
Kin2 acting in the secretory pathway by positively regulat-
ing Sec9 function.
DISCUSSION
Novel Role for Par-1: Regulation of Exocytosis
Par-1 is a key regulator of polarity-axis formation in a num-
ber of organisms. This includes the anterior-posterior axis of
the C. elegans zygote and the Drosophila oocyte and the
apico-basal axis of polarized epithelia in Drosophila and
mammalian cells. Par-1 has been proposed to regulate cell
fate determination and polarized cell morphology by posi-
tioning polarity markers, modulating activity of signaling
pathways such as Wnt (canonical) and phencyclidine (pla-
nar cell polarity) and reorganizing the microtubule cytoskel-
eton (Kemphues et al., 1988; Drewes et al., 1997; Tenenhaus et
al., 1998; Shulman et al., 2000; Cox et al., 2001; Huynh et al.,
2001; Sun et al., 2001; Vaccari and Ephrussi, 2002; Benton and
Johnston, 2003; Doerflinger et al., 2003; Cohen et al., 2004).
This is the first report linking Par-1 to regulation of exo-
cytosis. Here, we show that the yeast Par-1 counterparts
Kin1 and Kin2 exhibit multiple genetic and physical inter-
actions with components of the exocytic machinery and thus
function in the post-Golgi secretory pathway in S. cerevisiae.
We demonstrate that both KIN1 and KIN2 suppress the
growth abnormality of rho3, rho3-V51, sec1, sec2, sec3, sec4,
sec10, and sec15, mutants of genes important for polarized
vesicle transport and docking. However, we observed that
neither KIN1 nor KIN2 suppress sec9-4 and sro7, sro77,
which are mutants of proteins involved in SNARE complex
assembly and fusion. Thus, our genetic data position Kin1
and Kin2 function between the vesicle docking and fusion
stages of exocytosis and identify these kinases as down-
stream effectors of the small GTPases: Rho3, Cdc42, Sec4,
and several components of the vesicle tethering machinery.
Moreover, these structurally homologous proteins display
functional redundancy as well, because they show an iden-
tical pattern of suppression of the late secretory mutants.
Consistent with genetic evidence, the analysis of physical
associations of Kin1 and Kin2 show that these proteins exist
in a complex with proteins necessary for fusion of exocytic
vesicles with the plasma membrane. We demonstrate that
Kin1 and Kin2 coimmunoprecipitate with the t-SNARE Sec9,
and the homologue of the Drosophila tumor suppressor lethal
giant larvae, Sro7, which has been previously reported to
bind to Sec9 (Lehman et al., 1999). Based on physical and
genetic data, we propose that Kin1 and Kin2 transmit a
signal from the upstream-acting GTPases and the docking
complex to the SNARE proteins to ensure correct vesicle
fusion.
How conserved is the role of Par-1 in exocytosis? A high
degree of functional conservation was observed for proteins
constituting the Golgi-to-cell surface vesicle delivery ma-
chinery, including the Exocyst complex and the SNARE
proteins (Kee et al., 1997; Rossi et al., 1997). Therefore, po-
tentially, a link between Par-1 and the polarized exocytic
machinery might represent a universal feature. Remarkably,
a collaboration with Dr. Anne Muesch (Cornell Medical
College, Ithaca, NY) revealed that mammalian Par-1 (EMK1)
exists in a protein complex with the basolateral t-SNARE
Syntaxin 4 and the Exocyst components in Madin-Darby
canine kidney (MDCK) cells (our unpublished data, per-
sonal communication), suggesting that Par-1 is involved in
the regulation of exocytosis in polarized mammalian cells as
well. Nevertheless, there are some differences between the
two systems. In MDCK cells, EMK1 interacts with the t-
SNARE Syntaxin 4 but not with the mammalian equivalent
of Sec9, SNAP25. On the other hand, our group did not
detect any association between Kin1/Kin2 and Sso1/2, the
yeast counterparts of the mammalian syntaxins. Thus, al-
though Par-1 function in exocytosis is likely to be conserved,
the precise molecular mechanism of signal transduction by
Par-1 might differ from species to species.
Mechanism of Kin1 and Kin2 Function
Analysis of a kinase-dead mutant of Kin1 and Kin2 in yeast
showed that the catalytic activity of these kinases is essential
for suppression of sec mutants and thus for function in
exocytosis. Therefore, we focused on finding a target and
downstream effector of Kin1 and Kin2 in the secretory path-
way. We assessed the ability of these kinases to phosphor-
ylate a number of components of the late exocytic machin-
ery, including the post-Golgi SNAREs. We found that the
t-SNARE Sec9 is the only protein out of those tested that is
phosphorylated in vivo upon overexpression of Kin1 and
Kin2. Although we cannot exclude the possibility that an-
other, as yet untested, component of the exocytic machinery
is the target of Kin1/2 function in this pathway, the genetic
and biochemical evidence provided here strongly suggests
that Sec9 is the ultimate target of Kin1/2 action on exocyto-
sis. Despite the fact that Sec9 can serve as a direct substrate
of Kin1 and Kin2 in vitro, analysis of a phospho-mutant of
Sec9 revealed that in vivo Kin1/Kin2-mediated phosphory-
lation of Sec9 is likely to be indirect. It is presently unclear
Table 4. Comparison of suppression properties of high copy KIN1,
KIN2 with those of high copy SEC9
Mutant 2 KIN1 2 KIN2 2 SEC9
rho3-V51cs   
sec1-1ts   
sec2-41ts   —
sec3-2ts / /- 
sec4-P48cs   
sec5-24ts — — —
sec6-4ts — — —
sec8-9ts — — 
sec9-4ts — — 
sec10-2ts   
sec15-1ts   
sro7, sro77 — — —
Secretory mutants were transformed with either vector (pRS426), KIN1,
KIN2, or SEC9 on high copy. Growth of transformants at permissive
(25°C) and restrictive temperatures was tested. The following restric-
tive temperatures were applied: 14°C for rho3-V51, 33°C for sec1-1,
33°C for sec2-41, 35°C for sec3-2, 14°C for sec4-P48, 33°C for sec5-24,
35°C for sec6-4, 37°C for sec8-9, 34°C for sec9-4, 35°C for sec10-2, 35°C for
sec15-1, and 19°C for sro7, sro77. Scoring reflects the mutant colony
growth at their respective restrictive temperatures relative to the wild-
type yeast () and empty vector control (—). Suppression of the sec
mutants is indicated as follows: , very strong; , strong; ,
moderate; /, weak.
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which protein kinase transmits the signal from Kin1/Kin2 to
Sec9.
How is the t-SNARE Sec9 regulated by yeast Par-1 ortho-
logues? Recent studies demonstrated that SNARE protein
stability, localization, and assembly into functional com-
plexes are amenable to regulation by phosphorylation and
dephosphorylation as is the final process of membrane fu-
sion itself (Foster et al., 1998; Cabaniols et al., 1999; Peters et
al., 1999; Risinger and Bennett, 1999; Chung et al., 2000;
Kataoka et al., 2000; Lin and Scheller, 2000; Verona et al.,
2000; Marash and Gerst, 2001; Pombo et al., 2001; Nagy et al.,
2002, 2004; Polgar et al., 2003; Tian et al., 2003). Here, we
show that Kin1 and Kin2 alter the intracellular distribution
of Sec9. At steady state, Sec9 is distributed approximately
equally between the cytosol and the membrane. We ob-
served that expression of Kin1 and Kin2 results in depletion
of the membrane pool of Sec9 and induces phosphorylation
of cytosolic Sec9. Thus, yeast Par-1 orthologues either re-
lease membrane-bound Sec9 or prevent its attachment to the
membrane by yet unknown mechanism involving phos-
phorylation of the t-SNARE. Our data suggest that Kin1 and
Kin2 transmit a signal to the secretory pathway by increas-
ing the level and, possibly, activity of Sec9 in the cytosol.
Consistent with this, overexpression of KIN1 and KIN2 pro-
duced the same effect as overexpression of SEC9 with re-
spect to restoration of the growth of a number of sec mu-
tants. The only mutant that we found to be rescued by KIN1
and KIN2, but not by SEC9 overexpression, is sec2, encoding
an exchange factor for Sec4. It can be either due to Kin1/
Kin2 having an additional function independent of regula-
tion of Sec9, or alternatively, Sec9 might require Kin1/Kin2-
induced phosphorylation to gain suppression of sec2.
The increase in the proportion of Sec9 in the cytosol in-
duced by Kin1 and Kin2 suggests a mechanism by which
their action promotes exocytosis. Previous work has sug-
gested that Sec9 represents the limiting component in the
formation of plasma membrane SNARE complexes and is
present in wild-type cells in molar amounts that are 5- to
10-fold lower than the other two SNAREs it forms com-
plexes with: Sso1/2 and Snc1/2 (Brennwald et al., 1994).
Therefore increasing amounts of Sec9 available for forma-
tion of SNARE complexes either by increasing overall Sec9
protein levels (i.e., increasing SEC9 dosage) or increasing the
proportion of free Sec9 available to form SNARE complexes
would be expected to have strong positive effect on exocytic
activity. However, it is known that SNARE complex assem-
bly occurs on the plasma membrane. How does the Kin1/2-
mediated release of Sec9 from the membrane into the cytosol
promote exocytosis?
It is likely that Kin1 and Kin2 phosphorylate and release
from the membrane free, unassembled Sec9 for two reasons.
First, we have not detected the interaction between Kin1/
Kin2 and two other exocytic SNAREs: the t-SNARE Sso and
the v-SNARE Snc. Second, we have not detected a dramatic
difference in the amount of Sec9 present in SNARE com-
plexes as a consequence of Kin1 or Kin2 activity (our un-
published observation), and thus this pathway does not
affect steady-state amounts of SNARE complexes present.
Nevertheless, it cannot be ruled out that Kin1 and Kin2
phosphorylate a fraction of Sec9 in “old”, inactive SNARE
complexes and initiate its release, priming Sec9 for a new
round of vesicle fusion.
Importantly, although it may seem contradictory that el-
evation of unassembled SNARE levels in the cytosol at the
expense of the membrane-bound pool promotes vesicle fu-
sion, we hypothesize that Sec9 is recruited from the cytosolic
rather than the membrane pool into new SNARE complexes.
Under this assumption, the more efficient release of Sec9
from the membrane induced by Kin1 and Kin2 phosphory-
lation replenishes the pool of assembly-competent Sec9 near
sites of recruitment. Consequently, increased cycling of Sec9
would promote complex assembly and vesicle fusion. Thus,
we think that Kin1 and Kin2 promote secretion by increasing
the pool of Sec9 available for incorporation into new, active
SNARE complexes.
It is also possible that Kin1 and Kin2 help to spatially
direct SNARE complex formation by locally priming Sec9
for assembly. In S. cerevisiae fusion of vesicles is restricted to
the tip of the bud. Nevertheless, the t-SNARE Sec9 is not
polarized, in fact, it localizes ubiquitously in the cytoplasm
and homogenously over the entire perimeter of the plasma
membrane (Brennwald et al., 1994). Distribution of the other
t-SNARE, Sso, is also nonpolar (Brennwald et al., 1994).
Therefore, other molecules are required to restrict formation
of fusion-competent SNARE complexes to the bud tip. Ex-
ogenous Kin1 and Kin2 localize ubiquitously in the cell (our
unpublished observation). However, based on our genetic
data, these kinases act downstream of molecules directing
polarized vesicle transport and docking, such as Rho3,
Cdc42, Sec4, and the Exocyst complex. Thus, Kin1 and Kin2
are likely to be activated and regulate Sec9 in a polarized
manner, possibly by phosphorylating and releasing Sec9
from the membrane locally, near the sites of fusion.
Structural Insights: the Conserved 42-Amino Acid Tail
Function in Autoinhibition
The C-terminal 42 amino acid tail sequence (termed “KA1”
domain) is highly conserved throughout Par-1 orthologues
from yeast to mammalian cells. Nevertheless, the role of this
conserved segment remained unknown. Our data show that
deletion of these 42 amino acids results in the gain of func-
tion of the kinase in the secretory pathway. Kin2 constructs
with a deletion of the tail display stronger suppression of the
growth defect of sec mutants relative to the wild-type kinase,
suggesting that the tail plays an inhibitory role. Binding of
the regulatory domain of the kinase to its catalytic core is a
known mechanism of kinase autoinhibition (Hu et al., 1994;
Tu et al., 1997; Tu and Wigler, 1999; Tan et al., 2001). Inhibi-
tion can happen via two scenarios: in cis, with one molecule
circling on itself (as shown in Figure 3D), and in trans,
mediated through head-to-tail dimer formation. In a
“closed” configuration an inhibitory segment inactivates a
kinase by blocking either the ATP- or the substrate-binding
sites. Consistent with this mechanism of autoinhibition, we
show that catalytic (N-terminal) and regulatory (C-terminal)
domains of Kin2 directly interact with each other and that
this interaction requires an intact 42 amino acid tail se-
quence. Hence, we provide functional and physical evidence
for the inhibitory role of the C-terminal tail. Considering a
remarkable degree of conservation of the tail sequence be-
tween Par-1 orthologues, it is likely that the autoinhibitory
function of the tail is conserved as well.
CONCLUSIONS
In summary, we report three novel findings. First, we dem-
onstrate that yeast Par-1 counterparts are associated with
and seem to positively regulate the function of the exocytic
apparatus. Second, we show that Kin1 and Kin2 induce
phosphorylation of Sec9 and its release from the plasma
membrane to the cytosol, promoting its recycling and/or
availability for incorporation into newly formed SNARE
complexes. Third, we find that the conserved 42-amino acid
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tail of the yeast Par-1 orthologues plays a role in autoinhi-
bition.
This suggests an interesting possibility that the role of
Par-1 in cell polarity establishment in a variety of organisms
might be tied to the control of Golgi-to-plasma membrane
vesicle targeting. It is possible to envision that the primary
function of Par-1 is to regulate polarized secretion, which in
turn is necessary for proper localization of polarity determi-
nants and microtubule capture/stabilization, processes that
require Par-1 in a number of species. It remains to be seen
how essential and conserved is the function of Par-1 in
exocytosis.
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